MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition

Gurkan Mollaoglu, Matthew R. Guthrie, Stefanie Böhm, Johannes Brägelmann, Ismail Can, Paul M. Ballieu, Annika Marx, Julie George, Christine Heinen, Milind D. Chalishazar, Haixia Cheng, Abbie S. Ireland, Kendall E. Denning, Anandaroop Mukhopadhyay, Jeffery M. Vahrenkamp, Kristofer C. Berrett, Timothy L. Mosbruger, Jun Wang, Jessica L. Kohan, Mohamed E. SalamaBenjamin L. Witt, Martin Peifer, Roman K. Thomas, Jason Gertz, Jane E. Johnson, Adi F. Gazdar, Robert J. Wechsler-Reya, Martin L. Sos, Trudy G. Oliver

Neuroscience
Pharmacology
Neuroscience
Pathology
Hamon Center For Therapeutic Oncology

Research output: Contribution to journal › Article › peer-review

355 Scopus citations

Sort by
Weight
Alphabetically

MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition

Fingerprint

Medicine & Life Sciences